Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Pediatr Diabetes ; 18(4): 315-319, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-27161659

RESUMEN

BACKGROUND/OBJECTIVE: The impact of family composition on glycemic control in children with type 1 diabetes remains unclear. We sought to evaluate the relationship between health insurance coverage, family composition, and insulin management, and assess their impact on glycemic control in a pediatric type 1 diabetes population. METHODS: A retrospective chart review was completed for patients seen in the Pediatric Endocrinology Clinic at the University of Louisville in 2012. RESULTS: The analysis included 729 patients with type 1 diabetes; 268 (37%) had public insurance while 461(63%) had private insurance. Compared with publicly insured patients, privately insured patients had higher rates of intensive insulin management with multiple daily injections (MDI) plans or pump devices (88 vs. 83.2%, p = 0.066) and lower HbA1c levels [8.57 vs. 9.39% (70 vs. 79 mmol/mol), p < 0.001]. Of the 729 patients, 243 were in single-adult homes (33%). Single-adult homes had higher HbA1c levels than two-adult homes, [9.3 vs. 8.6% (78 vs. 70 mmol/mol), p < 0.001]. Among publicly insured, there was no difference in HbA1c levels for single-adult vs. two-adult homes [9.4 (79 mmol/mol), p = 0.868]. For privately insured, patients in single-adult homes had higher HbA1c levels than peers in two-adult homes [9.2 vs. 8.4% (77 vs. 68), p < 0.001]. CONCLUSION: Insurance type and family composition have significant associative effects on glycemic control and insulin management that may be mitigated by insulin pump therapy. Identifying and addressing factors such as availability of resources, family education, and adult support and supervision, may help improve glycemic control in high-risk pediatric diabetes patients.


Asunto(s)
Diabetes Mellitus Tipo 1/tratamiento farmacológico , Familia , Hiperglucemia/prevención & control , Hipoglucemiantes/administración & dosificación , Insulina/administración & dosificación , Seguro de Salud , Automanejo , Biomarcadores/sangre , Estudios de Cohortes , Terapia Combinada/economía , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/economía , Diabetes Mellitus Tipo 1/terapia , Esquema de Medicación , Femenino , Hemoglobina Glucada/análisis , Gastos en Salud , Hospitales Universitarios , Humanos , Hiperglucemia/economía , Hipoglucemiantes/economía , Hipoglucemiantes/uso terapéutico , Insulina/economía , Insulina/uso terapéutico , Sistemas de Infusión de Insulina/economía , Kentucky , Masculino , Servicio Ambulatorio en Hospital , Estudios Retrospectivos , Automanejo/economía , Padres Solteros
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA